Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008814
Filing Date
2023-05-09
Accepted
2023-05-09 16:08:37
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20230331x10q.htm   iXBRL 10-Q 1159708
2 EX-31.1 omer-20230331xex31d1.htm EX-31.1 11024
3 EX-31.2 omer-20230331xex31d2.htm EX-31.2 12227
4 EX-32.1 omer-20230331xex32d1.htm EX-32.1 8169
5 EX-32.2 omer-20230331xex32d2.htm EX-32.2 7720
  Complete submission text file 0001558370-23-008814.txt   6292442

Data Files

Seq Description Document Type Size
6 EX-101.SCH omer-20230331.xsd EX-101.SCH 54892
7 EX-101.CAL omer-20230331_cal.xml EX-101.CAL 71522
8 EX-101.DEF omer-20230331_def.xml EX-101.DEF 168897
9 EX-101.LAB omer-20230331_lab.xml EX-101.LAB 427395
10 EX-101.PRE omer-20230331_pre.xml EX-101.PRE 326406
66 EXTRACTED XBRL INSTANCE DOCUMENT omer-20230331x10q_htm.xml XML 1190590
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 23902013
SIC: 2834 Pharmaceutical Preparations